The Supreme Court turned up the heat on Bayer on Tuesday, pressing the chemical giant on whether it adequately warned consumers about potential cancer risks tied to its widely-used Roundup herbicide.
The justices grilled company lawyers during oral arguments in a case that could reshape how manufacturers disclose health hazards on consumer products. Bayer faces thousands of lawsuits from customers who allege that exposure to Roundup caused them to develop cancer, a claim the company has consistently denied.
The central legal question centers on whether Roundup's labeling met federal safety standards and whether Bayer had a duty to provide stronger warnings to users. The court's line of questioning suggested skepticism about the adequacy of current disclosures, with justices pushing back on arguments that existing labels were sufficient.
Roundup, which contains glyphosate as its active ingredient, became one of the most commonly used pesticides in American agriculture and residential landscaping. The product's widespread adoption made it a commercial powerhouse for Bayer, especially after the company's acquisition of Monsanto in 2018.
The litigation represents one of the largest mass tort battles facing any corporation. Thousands of cases are pending in state and federal courts, with plaintiffs seeking damages and claiming Bayer downplayed or ignored warnings about cancer risks that internal documents allegedly show the company knew about.
A ruling from the Supreme Court could influence not just this dispute but the broader landscape of product liability law and what companies must communicate to consumers about potential health dangers.
Author James Rodriguez: "The justices clearly weren't buying Bayer's defense, and that's a warning sign for every manufacturer counting on minimal labeling requirements to shield themselves from liability."
Comments